medigraphic.com
ISSN 1561-3054 (Electronic)

2022, Number 1

<< Back Next >>

Rev Cubana Med Trop 2022; 74 (1)

Evaluation of real-time PCR kits to detect high-risk human papillomavirus.

Soto BY, Sánchez DY, Ortega LD, Kourí CV, Palenzuela DA, Rodríguez LLÁ, González GYJ, Ramirez CC, Baños MY

Language: Spanish
References: 26
Page:
PDF size: 347.37 Kb.


ABSTRACT

Introduction: The use of molecular techniques for the diagnosis of high oncogenic risk human papillomavirus (hrHPV) is crucial for the early detection of cervical cancer.
Objective: To evaluate the analytical performance of two real-time PCR kits, commercialized by the Cuban Immunoassay Center, to detect hrHPV.
Methods: Two DNA panels from cervical samples were used: one with 150 samples to validate the SUMASIGNAL HPV 16/18 kit, the DNA extraction process and its usefulness as a quantitative test; and another with 163 samples to evaluate the HPV 13+2 kit. The clinical utility of the HPV 13+2 kit was determined in 55 self-collected cervicovaginal samples. The analytical performance indicators of both kits were calculated with respect to reference tests.
Results: Performance indicators for SUMASIGNAL HPV 16/18 were excellent (>95%), concordance 96%, kappa index=0.93 [0.85-1.01]. DNA extraction showed 100% clinical and analytical specificity and 95% analytical sensitivity. Good correlation was obtained with the quantitative reference test (r = + 0.688). The HPV 13+2 kit had 100% clinical specificity and sensitivity, analytical specificity was 84% due to cross-reactivity with other hrHPVs. Its clinical application revealed a high frequency of infection (41.8%): 23.6% with hrHPV, particularly in young women (50%). The self-collected sample was viable (100%).
Conclusion: The assays evaluated showed high quality standards, which would allow their use with national coverage in a technological platform available for the whole country.


REFERENCES

  1. zur Hausen H. Papillomaviruses in the causation of human cancers (a brief historical account. Virology. 2009 [Acceso 06/06/2021];384(2):260-5. Disponible en: https://www.sciencedirect.com/science/article/pii/S0042682208007721

  2. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2019 [Acceso 06/06/2021];30(Suppl 5):F12-23. Disponible en: https://www.researchgate.net/publication/233836601_Global_Burden_of_Human_Papillomavirus_and_Related_Diseases

  3. de Villiers EM. Cross-roads in the classification of papillomaviruses. Virology. 2013 [Acceso 06/06/2021];445(1-2):2-10. Disponible en: https://www.sciencedirect.com/science/article/pii/S0042682213002456?via%3Dihub

  4. Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer. 2009 [Acceso 07/06/2021];124(3):516-20. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789446/

  5. Paz-Zulueta M, Alvarez-Paredes L, Rodriguez Diaz JC, Paras-Bravo P, Andrada Becerra ME, Rodriguez Ingelmo JM, et al. Prevalence of high-risk HPV genotypes, categorized by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions. BMC Cancer. 2018 [Acceso 07/06/2021];18(1):112. Disponible en: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4033-2

  6. Santana-Martinez AA, Bermejo-Bencomo W, Solares-Azteasuinzarra AM, Camacho-Canino T, Lopez-Soto MV, Silveira-Pablos JM, et al. Programa integral para el control del cáncer en Cuba. Algoritmos de atención para las consultas de patologías de cuello. In: Cuba MdSPd, ed. La Habana, Cuba: Ciencias Médicas. Centro Nacional de Información de Ciencias Médicas; 2019. [Acceso 07/06/2021]. Disponible en: http://www.bvs.sld.cu/libros/programa_integral_consulta_patol_cuello/programa_integral_patologia_cuello.pdf

  7. AEdS 2019. Anuario Estadístico de Salud 2019. Especial ed. La Habana: Oficina Nacional de Estadísticas e Información de la Dirección Nacional de Registros Médicos, Ministerio de Salud Pública de Cuba; 2020. p. 1-191. [Acceso 08/06/2021]. Disponible en: https://files.sld.cu/bvscuba/files/2020/05/Anuario-Electr%c3%b3nico-Espa%c3%b1ol-2019-ed-2020.pdf

  8. Cheng JY, Bian ML, Ma L, Cong X, Chen Y, Liu J. Evaluation of variable methods for HPV testing. Zhonghua Fu Chan KeZaZhi. 2013 [Acceso 08/06/2021];48(8):589-94. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24199924/

  9. Jentschke M, Soergel P, Hillemanns P. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples. J Virol Methods. 2013 [Acceso 20/06/2021];193(1):131-4. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0166093413001894?via%3Dihub

  10. Soto Y, Kourí V, Martínez PA, Correa C, Torres G, Goicolea A, et al. Standardization of a real-time based polymerase chain reaction system for the quantification of human papillomavirus of high oncogenic risk. Vaccimonitor. 2012 [Acceso 20/06/2021];21(1):30-7. Disponible en: http://scielo.sld.cu/pdf/vac/v21n1/vac07112.pdf

  11. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009 [Acceso 20/06/2021];10(4):321-2. Disponible en: https://www.researchgate.net/publication/24261668_A_Review_of_Human_Carcinogens-Part_B_Biological_Agents

  12. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2018;310(20):2191-94. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/1760318?appId=scweb

  13. Van Delden J, Van der Graaf R. Revised CIOMS International Ethical Guidelines for Health-Related Research Involving Humans. JAMA. 2016 [Acceso 22/06/2021];317(2):135-6. Disponible en: https://jamanetwork.com/journals/jama/article-abstract/2592245

  14. Ochoa-Sangrador C, Molina-Arias M. Evaluación de la precisión de las pruebas diagnósticas. Variables discretas. Evid Pediatr. 2017 [Acceso 22/06/2021];13:28. Disponible en: https://evidenciasenpediatria.es/files/41-13048-RUTA/Fundamentos_MBE_28.pdf

  15. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010 [Acceso 22/06/2021];401(1):70-9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400342/pdf/nihms391325.pdf

  16. Tao K, Yang J, Yang H, Guo ZH, Hu YM, Tan ZY, et al. Comparative study of the cervista and hybrid capture 2 methods in detecting high-risk human papillomavirus in cervical lesions. Diagn Cytopathol. 2014 [Acceso 30/06/2021];42(3):213-7. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/dc.23025

  17. Depuydt CE, Benoy IH, Beert JF, Criel AM, Bogers JJ, Arbyn M. Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening. J Clin Microbiol. 2012 [Acceso 30/06/2021];50(12):4073-7. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503006/pdf/zjm4073.pdf

  18. Zhang Q, Dong B, Chen L, Lin T, Tong Y, Lin W, et al. Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China. Cancer Manag Res. 2020 [Acceso 30/06/2021];12:2369-79. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132552/pdf/cmar-12-2369.pdf

  19. Hernández-Lalinde J, Espinosa-Castro JM, Penaloza-Tarazona ME, Díaz-Camargo E, Bautista-Sandoval M, Riaño-Garzón ME, et al. Sobre el uso adecuado del coeficiente de correlación de Pearson: verificación de supuestos mediante un ejemplo aplicado a las ciencias de la salud. Arch Venez de Farmacol y Terapeut. 2018 [Acceso 30/06/2021];37(5):434-43. Disponible en: https://www.researchgate.net/publication/331894945_Sobre_el_uso_adecuado_del_coeficiente_de_correlacion_de_Pearson_verificacion_de_supuestos_mediante_un_ejemplo_aplicado_a_las_ciencias_de_la_salud

  20. Sargent A, Theofanous I, Ferris S. Improving laboratory workflow through automated pre-processing of SurePath specimens for human papillomavirus testing with the Abbott Real Time assay. Cytopathology. 2019 [Acceso 02/07/2021];30(5):532-7. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1111/cyt.12737

  21. Pan C, Zhou J, Lyu J, Ren X. Development and validation of a multiplex reverse transcript real-time PCR for E6/E7 mRNA detection of high-risk human papillomavirus. J Med Microbiol. 2018 [Acceso 02/07/2021];67(10):1509-14. Disponible en: https://www.microbiologyresearch.org/docserver/fulltext/jmm/67/10/1509_jmm000824.pdf?expires=1628709544&id=id&accname=guest&checksum=B551D0AF2A88D8F3D328616691C6CB5F

  22. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010 [Acceso 02/07/2021];202(12):1789-99. Disponible en: https://academic.oup.com/jid/article/202/12/1789/2192082

  23. Soto Y, Torres G, Kouri V, Limia CM, Goicolea A, Capo V, et al. Molecular Epidemiology of Human Papillomavirus Infections in Cervical Samples From Cuban Women Older Than 30 Years. J Low Genit Tract Dis. 2014 [Acceso 03/07/2021];18(3):210-17. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24270200

  24. Soto Y, Limia CM, Kouri V, Goicolea A, Capo de Paz V, Mune M. Papilomavirus humanos y otros factores asociados al desarrollo de lesiones cervicouterinas en mujeres cubanas. Panorama Cuba y Salud 2016 [Acceso 03/07/2021];11(1):24-33. Disponible en: https://www.redalyc.org/pdf/4773/477355397005.pdf

  25. Guilarte-García E, Soto-Brito Y, Kourí-Cardellá V, Limia-León CM, Sánchez-Alvarez ML, Rodríguez-Díaz AE, et al. Circulation of Human Papillomavirus and Chlamydia trachomatis in Cuban Women. MEDICC Review. 2020 [Acceso 03/07/2021];22(1):17-27. Disponible en: https://mediccreview.org/wp-content/uploads/2020/02/MR-January2020-Guilarte-Circulation-Human-Papillomavirus.pdf

  26. Onuma T, Kurokawa T, Shinagawa A, Chino Y, Yoshida Y. Evaluation of the concordance in HPV type between self- and physician-collected samples using a brush-based device and a PCR-based HPV DNA test in Japanese referred patients with abnormal cytology or HPV infection. Int J Clin Oncol. 2020 Oct;25(10):1854-60. DOI: https://doi.org/10.1007/s10147-020-01727-5




2020     |     www.medigraphic.com